Biotech 2050 Podcast cover image

Transforming Gene Therapy: Exclusive Insights from Zandy Forbes, President & CEO of MeiraGTx

Biotech 2050 Podcast

CHAPTER

Challenges of Transitioning to a Public Company CEO in the Biotech Industry

Exploring the pitfalls faced by private company CEOs transitioning to public company CEOs in the biotech sector, focusing on issues like understanding investor lexicon, clinical trial criteria, unexpected setbacks, and communication challenges. The chapter also features insights from a biotech CEO on their personal struggles, reflections, and the importance of perseverance and continuous improvement in the industry.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner